A new "R3 Report" from the Joint Commission (JC) offers hospitals information on ways to prevent catheter-associated urinary tract infections (UTIs) in hospitals.

Eighteen Georgia healthcare providers are the first in the state to receive payments from the Medicaid EHR Incentive Program being administered by the Georgia Department of Community Health Office of Health IT.

While procedures have become more precise and cardiovascular outcomes have improved, we still see cases of stenting and imaging overuse as well as cases of diagnostic procedures being underutilized. These instances force the questionhow much care is too much or too little?

The American Academy of Orthopaedic Surgeons (AAOS) has updated its clinical practice guideline to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline advises against routinely screening patients after surgery using ultrasound imaging and suggests use of preventive treatments.

Hypofractionation regimens of radiation therapy, which deliver higher doses of radiation per day, but in fewer days, are as effective in decreasing intermediate to high-risk prostate cancer from returning as conventional radiation therapy at five years post-treatment, according to a randomized trial to be presented at the 53rd Annual Meeting of the American Society for Radiation Oncology (ASTRO) in Miami, Oct. 2-6.

The FDA's Office of Orphan Products Development (OOPD) announced the 2011/2012 recipients of the Pediatric Device Consortia Grant Programs.

After health authorities re-read 14,000 CT studies, x-rays and mammograms, British Columbia Health Minister Michael de Jong reported Sept. 27 that a series of patients were misdiagnosed or faced delayed treatment based on the initial interpretation rendered by one of four radiologists. de Jong announced an action plan to strengthen physician hiring and restore public confidence in the healthcare system.

Boston Scientific's subsidiary Guidant is on the hook for $9.25 million because it inflated the cost of pacemakers and implantable cardioverter-defibrillators sold to hospitals and reneged on credits owed the Department of Veterans Affairs for replacement of units still under warranty.